宏力醫療管理集團有限公司 09906Stock Information

Stock Information · Old Rules
// Company Overview //
Stock Name宏力醫療管理集團有限公司
Stock Code09906
Company Full Name宏力醫療管理集團有限公司
Industry醫療保健
Principal Activities主要在中國河南省經營醫院。
Listing Date2020-07-13
Listing Rules EraOld Rules
Listing Rules ChapterNo data
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國河南省長垣縣博愛路南段8號
Business Address (Hong Kong)No data
Place of IncorporationNo data
Listing MethodNo data
Listing BoardMain Board
Websitehttp://www.honlivhp.com
Share Registrar卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar Contact(852)2862 8628
A-Share/US Dual ListingNo data
// Offering Information //
Prospectus Date2020-06-24
Offer PriceHK$ 2.10 / shares
Total Funds RaisedHK$ 31,500,000
// Valuation & Financials //
Market Cap (at Offer Price)HK$ 0
// First Day Performance
First Day CloseLoading...
First Day OpenHK$ 2.6
First Day Change15.24%
First Day Volume52223000.0
First Day Turnover128023000.0
// Price Chart //
Loading...
// Use of Proceeds
Use of Proceeds1、約28.7%或76.5百萬港元(相等于人民幣70.0百萬元)將用于為擴建一期大樓提供資金; 2、約27.1%或72.1百萬港元(相等于人民幣66.0百萬元)將透過收購醫院用于擴展我們的業務; 3、約15.0%或40.0百萬港元(相等于人民幣35.6百萬元)將用于償還一般借款(特別是來自兩家銀行的未償還貸款; 4、約10.0%或26.6百萬港元(相等于人民幣24.4百萬元)將用作營運資金及其他一般企業用途; 5、約8.0%或21.3百萬港元(相等于人民幣19.5百萬元)將用于購買醫療設備,并改善及提升我們的信息技術系統; 6、約6.2%或16.4百萬港元(相當于人民幣15.0百萬元)將用于發展我們的藥品供應鏈業務; 7、約5.0%或13.3百萬港元(相當于人民幣12.2百萬元)將用于僱員招聘及培訓。
// Underwriting Syndicate //
独家保荐人 (1)
交银国际(亚洲)有限公司
整体协调人 (2)
交银国际证券有限公司 招银国际融资有限公司
联席账簿管理人 (8)
交银国际证券有限公司 招银国际融资有限公司 盛源证券有限公司 华泰金融控股(香港)有限公司 金桥证券有限公司 海通国际证券有限公司 农银国际证券有限公司 尚乘环球市场有限公司
联席牵头经办人 (12)
交银国际证券有限公司 招银国际融资有限公司 盛源证券有限公司 华泰金融控股(香港)有限公司 金桥证券有限公司 海通国际证券有限公司 农银国际证券有限公司 尚乘环球市场有限公司 中泰国际证券有限公司 天大证券有限公司 瑞丰国际证券有限公司 佳富达证券有限公司
// Cornerstone Investors //
#Investor NameInvestment AmountShares Subscribed% of Offer Shares% of Total SharesLock-up PeriodEst. Unlock Date
1 长垣市投资集团有限公司 61,210,800 HKD 19.43% 6 months 2021-01-13
// Directors & Management //
Chairman秦巖
Company Secretary王曉陽;楊兆琳
No director data available.
// Major Shareholders //
Major Shareholders & Holdings秦巖(51.80%);秦紅超(22.20%)
Disclaimer & Risk Warning

Site Nature: This website (cibo.qizai.ai) is an independent technology product showcase platform established by Panda Securities Limited (CE Number: BNC380). This website itself and all content displayed herein do not constitute and are not involved in any regulated activity or licensed service.

Not Investment Advice: The data on this page is automatically extracted from prospectus PDFs by AI and may contain omissions or errors. Some data is supplemented from HKEX New Listing Reports ([HKEX]). All information and data on this page are sourced from prospectuses and related historical documents, are not real-time data, and will not be automatically updated, reflecting historical information at the time of prospectus publication. All content is provided solely for AI tool analysis learning exchange and technical reference purposes, and absolutely does not constitute any investment advice, offer to buy or sell, solicitation, recommendation, or guarantee. The output of this AI analysis tool should not be interpreted as investment opinion.

Decision Responsibility: Users should make investment decisions based on their own independent judgment and consult independent licensed financial advisors when needed. Neither the Company nor this AI analysis tool shall bear any responsibility for any investment decisions made by users based on the information on this page.

Separation from Panda Securities Official Website: The content of this website is strictly distinct from the SFC-regulated licensed services provided by Panda Securities' official website (fafa.hk). No securities trading or account opening or other regulated operations can be conducted through this website.

Panda Securities Limited is a licensed corporation regulated by the Hong Kong SFC (CE Number: BNC380) and a Hong Kong Exchange Participant (Participant ID: 02229). Use of this website constitutes acceptance of this disclaimer.

Cibo — IPO & Market Data Analytics